Incidence of Intraoperative Awareness in Indian Patient Population
Primary Purpose
Intraoperative Awareness
Status
Recruiting
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Bi-spectral Index (BIS QUATRO REF #186-0106)
End tidal anaesthesia gas concentration (ETAG)
Sponsored by
About this trial
This is an interventional prevention trial for Intraoperative Awareness
Eligibility Criteria
Inclusion Criteria:
- Male or female gender
- Aged 18-65 yrs.
- ASA Physical Status I/II
- General Anaesthesia
- Elective Surgery
- Surgery duration > 30-minutes
- Consenting for follow-up
Exclusion Criteria:
- Uncompensated systemic co-morbidity
- Cardiac and Neurosurgical procedures
- Head & Neck surgery
- Obstetric surgery
- Emergency surgery
- Anticipated difficult airway
- H/O brain injury, EEG abnormality
- Neuropsychiatry disorders
- Substance abuse (opioids, alcohol, recreational drugs, benzodiazepine)
- Pacemakers & Electronic implants
- Obesity (BMI>30kg/m2)
- Adhesive allergy
Sites / Locations
- Sir Ganga Ram HospitalRecruiting
- Prof. L ParthasarathyRecruiting
- Post Graduate Institute For Medical Education & Research
- Apollo Gleneagles HospitalRecruiting
- P D Hinduja Hospital & Medical Research CentreRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
BIS Guided Group
ETAG Guided Group
Arm Description
GA will be monitored and controlled with Bi-spectral index (BIS) monitoring.The anaesthesiologist will be blinded to ETAG and MAC readings.
GA will be monitored and controlled with end-tidal anaesthesia gas (ETAG) monitoring.The anaesthesiologist will be blinded to the BIS readings.
Outcomes
Primary Outcome Measures
Incidence of intraoperative awareness
Will be assessed using Modified Brice Interview and Michigan awareness classification instrument
Secondary Outcome Measures
Intraoperative Bi-spectral index (BIS) score
BIS values will be recorded from the patient monitor
Intraoperative End-tidal anaesthesia gas (ETAG) concentration
ETAG concentration will be recorded from the patient monitor
Intraoperative minimum alveolar concentration (MAC)
MAC will be recorded from the patient monitor
Recovery from anaesthesia
Time taken by the patient to open his/her eyes after discontinuation of anaesthesia will be noted
Recovery from anaesthesia
Time taken for tracheal extubation after discontinuation of anaesthesia will be noted
Changes in intra-operative heart rate (beats per minute)
Comparison of intra-operative heart rate between both the arms will be done
Change in Intra-operative blood pressure - systolic , diastolic, and mean (mmHg)
Comparison of intra-operative blood pressure- systolic, diastolic, and mean between both the arms will be done
Postoperative Sedation
Will be assessed using Modified Observer's assessment of alertness/sedation scale (OASS). This scale measures postoperative sedation on a scale of 0 to 5. A score of '0' indicates patient is deeply sedated with no response to any stimuli , whereas a score of 5 indicates that the patient is wide awake.
Postoperative Nausea and Vomiting (PONV)
Will be assessed using postoperative nausea and vomiting (PONV) Scale. The scale measures PONV on a scale of 0 to 2. A score of '0' indicates that the patient has no emetic symptoms, whereas a score of '2' indicates that the patient has vomiting.
Postoperative Analgesia
Will be assessed using 10-point Visual Analogue Scale (VAS) Score which measures pain on a scale of 0 to 10. A score of '0' indicates that the patient is free of pain whereas a score of '10' indicates that patient has severe pain.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03571945
Brief Title
Incidence of Intraoperative Awareness in Indian Patient Population
Official Title
Impact of Bi-spectral Index Guided Inhalation Anaesthesia on the Incidence of Intraoperative Awareness in Indian Patient Population: A Prospective, Randomised, Multi-Centric Study
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 10, 2018 (Actual)
Primary Completion Date
March 2, 2025 (Anticipated)
Study Completion Date
March 2, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sir Ganga Ram Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The profiling of bi-spectral index (BIS) monitored facilitation of general anesthesia (GA), including, anesthesia induction and maintenance of GA depth state, emergence characteristics, and postoperative recovery parameters, is now extensively available. However, majority of the data supporting the use of BIS have emanated from western Caucasian patient population. Though research on BIS monitoring have also emerged from Asian subcontinent, the data generated, at the best, is too scattered, random, and non-homogenous to reflect onto how BIS guidance fares in Asians on a population basis. We aim to undertake a multi-centric prospective cohort trial in Asian patient population to analyze as to whether BIS guidance toes the profiling and the evidence in Caucasians.
Detailed Description
After Institutional Ethics Committee approval and informed written patient consent, 2000 patients justifying inclusion and exclusion criteria ( will be included in this National, multi-centric, prospective, randomised, double-blind (patients, analyst), 2- arm trial.
All the patients scheduled for elective surgery under general anaesthesia will be randomly (simple computer generated random number table) allocated to one of the following two groups:
Group I [BIS Guided Group, n=1000]: GA will be monitored and controlled with Bi-spectral index (BIS).
Group II [ETAG Guided Group, n=1000]: GA will be monitored and controlled with end-tidal anaesthesia gas concentration (ETAG).
Sample Size Estimation To detect a difference in incidence of awareness of 0.04 % (a rate based on Mashour et al, Anesthesiology 2012) between the ETAG and BIS-guided group a total of 1800 patients will be required at a power of 80% with a type-II error 0f 0.5. To compensate for possible drop outs 10% additional patients will be recruited for the study. Therefore, the total sample size will include 2000 patients.
Randomization concealment: will be done using opaque sealed envelopes with alphabetic codes. In addition, before opening the envelope patient's data slip will be pasted on the envelopes.
Blinding: Investigator, assessor and the data analyst will be blinded to the method of GA (BIS or ETAG guided) Subgroup Analysis: Subgroup analysis will be specifically performed and reported if the data shows gender equivalence (i.e., at least 40% patients of either sex in each group).
Anaesthesia Technique:
Routine monitoring (EtCO2, pulse oximetery, EKG, NIBP) will be applied during the procedure. Anaesthesia will be induced with fentanyl 2-mcg/kg and propofol 1.5-2.5 mg/kg. Non-depolarizing muscle relaxant (vecuronium/ rocuronium/ atracurium) will be administered to facilitate tracheal intubation. GA will be maintained with inhalation regimen (sevoflurane/desflurane-oxygen-air mixture) to target age-related MAC range of 0.7 to 1.3. Corresponding BIS score and end-tidal agent concentration will be noted at 5-minute interval. While, in the BIS group the anaesthesiologist will be blinded to ETAG and MAC readings, in the ETAG group BIS display will be turned off. However, ETAG and MAC data will both be analyzed once the study is over. Although, the MAC will be titrated to haemodynamic goals (+20% baseline of SBP/MAP/Heart rate), it will be maintained within the prescribed range. On either side of the range of MAC, the haemodynamic depression/ activation will be responded to with vasopressor/vasodilators. At the end of surgery inhalation agent delivery will be stopped. The residual neuromuscular blockade will be reversed with neostigmine and glycopyrrolate.
The patients will be extubated once wide-awake and following commands. ASSESSMENT PARAMETERS Analysis of Intraoperative Awareness Quantitative: The participants will be subjected to modified Brice Interview 20 24-hours after surgery and after one month. The Brice interview at one month will be undertaken through telephonic contact and if awareness is present on any or both the occasions, a three-member independent awareness committee will review the incidence intensively. The awareness will be adjudicated in broad divisions, including, definite, possible, and no awareness. 21 No Awareness: No awareness or a perception of awareness that has a high probability of occurrence in the preoperative and the postoperative period.
Possible Awareness: There is a perception of awareness but the patient is unable to recall any event definitive indicative of awareness.
Definite Awareness: Perception of awareness that has clear recall or has a high likelihood of occurring in the intraoperative period.
Qualitative: After adjudication of a definite awareness by the awareness committee, the participants will be classified on the awareness pattern using the Michigan awareness classification instrument. 21 Class 1 will be defined by isolated auditory perception, Class 2 by tactile perceptions, Class 3 by pain experience, Class 4 by a feeling of paralysis and helplessness to move, and Class 5 by the presence of both paralysis and pain. If the awareness event is associated with distress the class will be modified with a suffix "D".
If definite awareness is present, the participants will be offered counselling sessions to ward off long-term behavioral changes and post-traumatic stress disorder (PTSD) The inter-reviewer observation will be analyzed for agreement using Fleiss's Kappa statistics for blinded assessment.
BIS score and end-tidal inhalation agent concentration: The intraoperative BIS scores and end-tidal inhalation agent concentration will be noted (every 5-minutes).
Time to awakening and tracheal extubation: Time (in minutes) to awakening will be noted after discontinuation of anaesthesia to point of first spontaneous eye opening. The time will be confirmed by the ability of the patient to obey commands. Time (in minutes) to tracheal extubation will comprise of the period after discontinuation of anaesthesia to tracheal extubation.
Statistical Analysis:
Demographic and procedural data will be analyzed with student's t-test, double sided, or the Chi-square test with Yate's correction as appropriate. Analysis of awareness outcome will be performed using Fisher's exact test. Sensitivity and specificity analysis will be undertaken for BIS values vis-à-vis explicit recall or no recall.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intraoperative Awareness
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
2000- patients aged 18-65 years scheduled for elective surgery under general anaesthesia will be randomly allocated to one of the following two groups:
Group I [BIS Guided Group, n=1000]: GA will be monitored and controlled with Bi-spectral index (BIS).
Group II [ETAG Guided Group, n=1000]: GA will be monitored and controlled with end-tidal anaesthesia gas concentration (ETAG).
Masking
ParticipantOutcomes Assessor
Masking Description
The attending anaesthesiologist will not be blinded to the method of administering GA (BIS or ETAG guided) and recovery immediately after extubation inside the OR. However, the postoperative evaluation of intraoperative awareness and patient recovery profile will be evaluated by an independent assessor blinded to the technique of GA.
Allocation
Randomized
Enrollment
2000 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
BIS Guided Group
Arm Type
Active Comparator
Arm Description
GA will be monitored and controlled with Bi-spectral index (BIS) monitoring.The anaesthesiologist will be blinded to ETAG and MAC readings.
Arm Title
ETAG Guided Group
Arm Type
Active Comparator
Arm Description
GA will be monitored and controlled with end-tidal anaesthesia gas (ETAG) monitoring.The anaesthesiologist will be blinded to the BIS readings.
Intervention Type
Device
Intervention Name(s)
Bi-spectral Index (BIS QUATRO REF #186-0106)
Intervention Description
GA will be monitored and controlled with Bi-spectral index (BIS).
Intervention Type
Device
Intervention Name(s)
End tidal anaesthesia gas concentration (ETAG)
Intervention Description
GA will be monitored and controlled with end-tidal anaesthesia gas concentration
Primary Outcome Measure Information:
Title
Incidence of intraoperative awareness
Description
Will be assessed using Modified Brice Interview and Michigan awareness classification instrument
Time Frame
From end of anaesthesia till 30-days postoperatively
Secondary Outcome Measure Information:
Title
Intraoperative Bi-spectral index (BIS) score
Description
BIS values will be recorded from the patient monitor
Time Frame
From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively
Title
Intraoperative End-tidal anaesthesia gas (ETAG) concentration
Description
ETAG concentration will be recorded from the patient monitor
Time Frame
From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively
Title
Intraoperative minimum alveolar concentration (MAC)
Description
MAC will be recorded from the patient monitor
Time Frame
From beginning of anesthesia (0-hours, baseline) till 8 hours intraoperatively
Title
Recovery from anaesthesia
Description
Time taken by the patient to open his/her eyes after discontinuation of anaesthesia will be noted
Time Frame
From end of anaesthesia till 20-minutes postoperatively
Title
Recovery from anaesthesia
Description
Time taken for tracheal extubation after discontinuation of anaesthesia will be noted
Time Frame
From end of anaesthesia till 20-minutes postoperatively
Title
Changes in intra-operative heart rate (beats per minute)
Description
Comparison of intra-operative heart rate between both the arms will be done
Time Frame
From beginning of anesthesia (0-hours, baseline) till 8 hours intra-operatively
Title
Change in Intra-operative blood pressure - systolic , diastolic, and mean (mmHg)
Description
Comparison of intra-operative blood pressure- systolic, diastolic, and mean between both the arms will be done
Time Frame
From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively]
Title
Postoperative Sedation
Description
Will be assessed using Modified Observer's assessment of alertness/sedation scale (OASS). This scale measures postoperative sedation on a scale of 0 to 5. A score of '0' indicates patient is deeply sedated with no response to any stimuli , whereas a score of 5 indicates that the patient is wide awake.
Time Frame
From end of anaesthesia till 24-hours postoperatively]
Title
Postoperative Nausea and Vomiting (PONV)
Description
Will be assessed using postoperative nausea and vomiting (PONV) Scale. The scale measures PONV on a scale of 0 to 2. A score of '0' indicates that the patient has no emetic symptoms, whereas a score of '2' indicates that the patient has vomiting.
Time Frame
From end of anaesthesia till 24-hours postoperatively]
Title
Postoperative Analgesia
Description
Will be assessed using 10-point Visual Analogue Scale (VAS) Score which measures pain on a scale of 0 to 10. A score of '0' indicates that the patient is free of pain whereas a score of '10' indicates that patient has severe pain.
Time Frame
From end of anaesthesia till 24-hours postoperatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female gender
Aged 18-65 yrs.
ASA Physical Status I/II
General Anaesthesia
Elective Surgery
Surgery duration > 30-minutes
Consenting for follow-up
Exclusion Criteria:
Uncompensated systemic co-morbidity
Cardiac and Neurosurgical procedures
Head & Neck surgery
Obstetric surgery
Emergency surgery
Anticipated difficult airway
H/O brain injury, EEG abnormality
Neuropsychiatry disorders
Substance abuse (opioids, alcohol, recreational drugs, benzodiazepine)
Pacemakers & Electronic implants
Obesity (BMI>30kg/m2)
Adhesive allergy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Amitabh Dutta, MD,PGDHR
Phone
+911142252523
Email
duttaamiatbh@yahoo.co.in
First Name & Middle Initial & Last Name or Official Title & Degree
Nitin Sethi, DNB
Phone
+919717494498
Email
nitinsethi77@yahoo.co.in
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amitabh Dutta, MD, PhD
Organizational Affiliation
Sir Ganga Ram Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Jayashree Sood, MD,FFRCA
Organizational Affiliation
Sir Ganga Ram Hospital
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Nitin Sethi, DNB
Organizational Affiliation
Sir Ganga Ram Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sir Ganga Ram Hospital
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110060
Country
India
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amitabh Dutta, MD, PGDHR
Phone
+911142252523
Email
duttaamiatbh@yahoo.co.in
First Name & Middle Initial & Last Name & Degree
Nitin Sethi, DNB
Phone
+919717494498
Email
nitinsethi77@yahoo.co.in
First Name & Middle Initial & Last Name & Degree
Anil K Jain, MD
First Name & Middle Initial & Last Name & Degree
Bhuwan C Panday, MD
First Name & Middle Initial & Last Name & Degree
Prabhat Choudhary, MD
First Name & Middle Initial & Last Name & Degree
Manish Gupta, MD
First Name & Middle Initial & Last Name & Degree
Savitar Malhotra, MD
First Name & Middle Initial & Last Name & Degree
Shvet Mahajan, DA, DNB
Facility Name
Prof. L Parthasarathy
City
Chennai
State/Province
Tamil Nadu
ZIP/Postal Code
600002
Country
India
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
L Parthasarathy, DA, MD
Phone
00919840049531
Email
drlpsarathy@gmail.com
Facility Name
Post Graduate Institute For Medical Education & Research
City
Chandigarh
Country
India
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Goverdhan D Puri, MD, PhD
Email
gdpuri007@hotmail.com
Facility Name
Apollo Gleneagles Hospital
City
Kolkata
ZIP/Postal Code
700054
Country
India
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Saikat Sengupta, MD
Email
saikatsg@gmail.com
Facility Name
P D Hinduja Hospital & Medical Research Centre
City
Mumbai
Country
India
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ratan Chelani
Email
rare.chels@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Incidence of Intraoperative Awareness in Indian Patient Population
We'll reach out to this number within 24 hrs